Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series-Reference-Cited by-同舟云学术

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series

Published:2016-01 Issue:1 Volume:22 Page:54-60
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pawarode Attaphol^ORCID,Mineishi Shin,Reddy Pavan,Braun Thomas M.,Khaled Yasser A.,Choi Sung W.,Magenau John M.,Harris Andrew C.,Connelly James A.,Kitko Carrie L.,Parkin Brian L.,Goldstein Steven C.,Yanik Gregory A.,Levine John E.,Ferrara James L.,Couriel Daniel R.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome;Attal;N Engl J Med,1996

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2003

5. National Comprehensive Cancer Network (NCCN) Multiple Myeloma Panel Members. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Multiple Myeloma, Version 4.2015. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#myeloma. 2015:Version 4.2015.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

3. Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood;International Journal of Hematology;2022-09-03

4. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04

5. Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors;Bone Marrow Transplantation;2020-09-02